P J Flegg

1.2k total citations
28 papers, 390 citations indexed

About

P J Flegg is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, P J Flegg has authored 28 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in P J Flegg's work include HIV/AIDS Research and Interventions (6 papers), HIV Research and Treatment (4 papers) and Salmonella and Campylobacter epidemiology (4 papers). P J Flegg is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), HIV Research and Treatment (4 papers) and Salmonella and Campylobacter epidemiology (4 papers). P J Flegg collaborates with scholars based in United Kingdom, Vietnam and United States. P J Flegg's co-authors include S. M. Burns, Clifford Leen, R.B.S. Laing, B K Mandal, David C. Kilpatrick, Ray P. Brettle, Geoffrey Haydon, Peter Hayes, R.P. Brettle and R P Brettle and has published in prestigious journals such as AIDS, Journal of Antimicrobial Chemotherapy and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

P J Flegg

26 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P J Flegg United Kingdom 13 172 168 100 60 45 28 390
Brendan McCarron United Kingdom 13 200 1.2× 130 0.8× 44 0.4× 137 2.3× 39 0.9× 23 378
Cecilia Tortajada Spain 11 122 0.7× 205 1.2× 106 1.1× 95 1.6× 21 0.5× 18 332
M. Paul United States 11 100 0.6× 249 1.5× 243 2.4× 11 0.2× 48 1.1× 15 461
Joanna Dobroszycki United States 9 141 0.8× 148 0.9× 192 1.9× 20 0.3× 22 0.5× 16 395
Nurgül Ceran Türkiye 15 239 1.4× 142 0.8× 17 0.2× 43 0.7× 38 0.8× 28 503
Bettina M. Knoll United States 12 169 1.0× 248 1.5× 22 0.2× 23 0.4× 53 1.2× 22 539
J. Colaert Belgium 13 230 1.3× 115 0.7× 29 0.3× 88 1.5× 53 1.2× 33 376
Robert E. Levitz United States 10 255 1.5× 113 0.7× 9 0.1× 80 1.3× 43 1.0× 15 440
E Dournon France 12 221 1.3× 241 1.4× 150 1.5× 7 0.1× 57 1.3× 55 661
K. Mohan United States 7 158 0.9× 185 1.1× 91 0.9× 16 0.3× 37 0.8× 9 336

Countries citing papers authored by P J Flegg

Since Specialization
Citations

This map shows the geographic impact of P J Flegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P J Flegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P J Flegg more than expected).

Fields of papers citing papers by P J Flegg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P J Flegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P J Flegg. The network helps show where P J Flegg may publish in the future.

Co-authorship network of co-authors of P J Flegg

This figure shows the co-authorship network connecting the top 25 collaborators of P J Flegg. A scholar is included among the top collaborators of P J Flegg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P J Flegg. P J Flegg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Head, Michael, et al.. (2017). Inadvisable anti-vaccination sentiment: Human Papilloma Virus immunisation falsely under the microscope. npj Vaccines. 2(1). 6–6. 3 indexed citations
2.
Flegg, P J, et al.. (2015). Gonococcal tenosynovitis in two HIV-infected heterosexual men: delayed diagnoses following negative urine nucleic acid amplification testing. International Journal of STD & AIDS. 27(6). 490–493. 5 indexed citations
3.
Page, Iain, Michael Phillips, P J Flegg, & Ruth Palmer. (2011). The impact of new national HIV testing guidelines at a district general hospital in an area of high HIV seroprevalence. The Journal of the Royal College of Physicians of Edinburgh. 41(1). 9–12. 11 indexed citations
4.
Khoo, Saye, Mark Dalton, Alec Bonington, et al.. (2006). Pharmacologic Optimization of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors (POPIN)-A Randomized Controlled Trial of Therapeutic Drug Monitoring and Adherence Support. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(4). 461–467. 45 indexed citations
5.
Haydon, Geoffrey, et al.. (1998). The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. European Journal of Gastroenterology & Hepatology. 10(6). 485–490. 51 indexed citations
6.
Laing, R.B.S., P J Flegg, R P Brettle, Clifford Leen, & S. M. Burns. (1996). Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. International Journal of STD & AIDS. 7(4). 258–264. 17 indexed citations
7.
Flegg, P J, et al.. (1995). Disseminated disease due to <italic>Mycobacterium avium</italic> complex in AIDS. QJM. 88(9). 617–26. 14 indexed citations
8.
Flegg, P J. (1994). The natural history of HIV infection: A study in Edinburgh drug users. Journal of Infection. 29(3). 311–321. 7 indexed citations
9.
Flegg, P J, R.P. Brettle, P D Welsby, et al.. (1992). Cytomegalovirus Disease in AIDS: The Edinburgh Experience. International Journal of STD & AIDS. 3(5). 324–328. 13 indexed citations
10.
Flegg, P J, et al.. (1992). Chloramphenicol Are Concerns About Aplastic Anaemia Justified?. Drug Safety. 7(3). 167–169. 9 indexed citations
11.
Willocks, Lorna, et al.. (1992). The spectrum of chest infections in HIV positive patients in Edinburgh. Journal of Infection. 24(1). 37–42. 12 indexed citations
12.
Flegg, P J & R.P. Brettle. (1991). AIDS in Edinburgh drug users: Observations on the epidemic and implications for its future management. Journal of Infection. 22(2). 113–118. 2 indexed citations
13.
Flegg, P J, et al.. (1991). β2-microglobulin levels in drug users. AIDS. 5(8). 1021–1024. 12 indexed citations
14.
Looareesuwan, S., Rodney E. Phillips, Juntra Karbwang, et al.. (1990). <italic>Plasmodium falciparum</italic> Hyperparasitaemia: use of Exchange Transfusion in Seven Patients and a Review of the Literature. QJM. 75(277). 471–81. 36 indexed citations
15.
Cowan, Frances M., P J Flegg, & R.P. Brettle. (1989). Heterosexually acquired HIV infection. BMJ. 298(6677). 891.4–891. 1 indexed citations
16.
Flegg, P J, et al.. (1989). Effect of zidovudine on platelet count.. BMJ. 298(6680). 1074–1075. 13 indexed citations
17.
Stanley, P, P J Flegg, B K Mandal, & A. M. Geddes. (1989). Open study of ciprofloxacin in enteric fever. Journal of Antimicrobial Chemotherapy. 23(5). 789–791. 22 indexed citations
18.
Cowan, Frances M., Graeme Jones, John Bingham, et al.. (1989). Use of zidovudine for drug misusers infected with human immunodeficiency virus. Journal of Infection. 18. 59–66. 6 indexed citations
19.
Leen, Clifford, et al.. (1989). Seven years experience of acute hepatitis B in a regional department of infectious diseases and tropical medicine. Journal of Infection. 18(3). 257–263. 2 indexed citations
20.
Mandal, B K, et al.. (1987). Ciprofloxacin in enteric fever.. PubMed. 6(2 Suppl). 492–3. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026